Canadian Cancer Trials Group Bulletins


Recent Publication

The primary results of Canadian Cancer Trials Group IND.183 (A Phase II Study of Sunitinib in Patients with Advanced Malignant Pleural Mesothelioma) were recently published in the Journal of Thoracic Oncology.

Laurie SA, Gupta A, Chu Q, Lee CW, Morzycki W, Feld R, Foo AH, Seely J, Goffin JR, Laberge F, Murray N, Rao S, Nicholas G, Laskin J, Reiman T, Sauciuc D, Seymour L. Brief Report: A Phase II Study of Sunitinib in Malignant Pleural Mesothelioma. The Canadian Cancer Trials Group. J Thoracic Oncol 6: 1950-4, 2011.